8-KOther Events

Monster Beverage Corp 8-K Report, Corporate Update (Mar 1, 2007)

Filed March 1, 2007For Securities:MNST

Summary

Hansen Natural Corporation (now Monster Beverage Corp.) announced on February 28, 2007, that the Nasdaq Listing Qualifications Panel has granted its request for continued listing on The Nasdaq Stock Market. This is a critical development for investors, as delisting would significantly impact liquidity and the company's public profile. The continued listing is contingent upon the company meeting several specific conditions within defined timelines. These conditions include submitting a final investigatory report or responding to Nasdaq's inquiries regarding stock option grants by March 26, 2007. Furthermore, by May 1, 2007, the company must secure shareholder approval for an out-of-plan stock option grant to a director or unwind the grant. Lastly, the company is required to file its Form 10-Q for the quarter ended September 30, 2006, and address any necessary restatements by May 14, 2007. Successfully meeting these requirements is paramount for maintaining investor confidence and market access.

Key Highlights

  • 1Nasdaq Panel grants Hansen Natural Corporation continued listing of its securities.
  • 2Continued listing is subject to specific conditions and deadlines.
  • 3Company must submit a final investigatory report or respond to Nasdaq inquiries on option grants by March 26, 2007.
  • 4Shareholder approval for a director's out-of-plan stock option grant, or unwinding the grant, is required by May 1, 2007.
  • 5Filing of the September 30, 2006 Form 10-Q, including any necessary restatements, is due by May 14, 2007.
  • 6These filings and actions are crucial for resolving past accounting and governance issues related to stock options.

Frequently Asked Questions

This 8-K filing primarily serves to inform investors that Hansen Natural Corporation (now Monster Beverage Corp.) has been granted continued listing on The Nasdaq Stock Market, subject to several important conditions.

The company must submit its final investigatory report on option grants or respond to Nasdaq's questions by March 26, 2007. By May 1, 2007, it needs shareholder approval for a specific director's stock option grant or must unwind it. Finally, the company must file its Q3 2006 Form 10-Q and any necessary restatements by May 14, 2007.

The investigation into stock option grants is critical because it likely relates to past accounting or governance concerns that put the company's Nasdaq listing at risk. Successfully resolving these issues is a prerequisite for continued listing and demonstrates improved compliance and transparency.

Filing the Q3 2006 Form 10-Q, including any necessary restatements, is essential for providing accurate financial reporting to investors and regulators. It indicates that the company is working to rectify any past financial reporting inaccuracies and is committed to meeting its ongoing disclosure obligations.